Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Some celebrities and social media influencers are taking the injection as a means to lose weight
[family insights were kindly provided by G E Hemsworth, Godfrey's nephew]
Saffron offers bioactive compounds (crocin and safranal) that directly modulate serotonin and dopamine, the neurotransmitters that govern mood stability, focus, and emotional resilience
For those with hypoglycemia, kidney problems, or allergies, serious side effects can arise
Nature Communications, 15, 1223